Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers
about
Ushering in the study and treatment of preclinical Alzheimer diseaseSex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct?Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyA clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings.Subjective cognitive decline: self and informant comparisonsCross-Sectional and Longitudinal Effects of CREB1 Genotypes on Individual Differences in Memory and Executive Function: Findings from the BLSAStructural imaging in early pre-states of dementia.Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review.Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis.The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's DiseaseThe role of APOE in cerebrovascular dysfunctionThe neuropsychology of normal aging and preclinical Alzheimer's diseaseAge and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease.Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?Moderate alcohol use and apolipoprotein E-4 (ApoE-4): Independent effects on cognitive outcomes in later life.Gray matter maturation and cognition in children with different APOE ε genotypes.Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.Meta-Analytic Evidence for a Reversal Learning Effect on the Iowa Gambling Task in Older Adults.Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.Genetic influences on cognition in progressive supranuclear palsy.APOE genotype and cognitive change in young, middle-aged, and older adults living in the community.Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment.Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course.A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.Brain Aging and APOE ε4 Interact to Reveal Potential Neuronal Compensation in Healthy Older Adults.
P2860
Q27014791-89266E5A-3EE2-474C-BD03-A85169F16FE1Q27302017-48C2C16F-3823-4534-A26C-424B66C0415AQ28282855-94DAA65C-F381-42C5-A5D5-9FE45BF2EB55Q30382854-4FF74A9C-9DB0-4035-8911-F7EDB4C3B895Q30421568-C31DC5B6-BFE7-4B18-B293-29DF7F0AF474Q33689729-E9D26A0F-B62C-404A-BBE8-4CD01362FD39Q33967561-37B484C5-CB53-45F1-A9B1-C9F6330811BFQ34180413-58ECB46F-2FC0-4BFF-8820-666338192DA1Q34303501-8CDD5262-D3AA-430C-9F97-55582C5B9827Q36090201-090E51A7-13FB-4D1D-9F52-C0D62ACB65A3Q36102989-E94A5875-6804-44CE-ABB0-0CBCB7C91309Q36729508-053F0A1B-BD40-46FD-907A-D46F3BFF8DABQ36744473-91CE6D7A-94C3-464C-9003-C0EF18C6A7ADQ36813704-37024FD8-B679-40E9-B89E-B080B0B31E31Q36979972-2CC1A70F-AD4A-4742-8E3C-ED972262F7DBQ37317664-91B3B094-F19C-46C2-B42F-F8677103E90EQ37615967-1453C5E4-16E0-4855-814C-1FD7F8D81F3FQ37691070-69FD0F31-EF01-4D0C-8A14-C0100B9FAC5AQ38150812-CDBD2363-D23A-4996-B5A3-58E0A6B1C971Q38665508-B0523118-BDD9-4D8C-9575-6AD85B12D2B3Q38842237-C2A435D7-A620-4A86-958A-1430398CCD4DQ38877586-88509471-A7D5-45AD-B52B-275FDBD1A369Q42699878-2BE48BB2-A3EB-408B-B613-11398A982D3EQ46082316-7B465AF4-610E-4BC4-A283-9A9BE66EAA85Q46338549-BD73D801-786E-44D5-A105-BA6F75ECBE2DQ46989840-36090815-4974-411E-8329-8A7F7A64CBABQ47550446-EFC2E3D8-5AC5-468E-84BE-15080547058DQ47653723-DA438779-27D9-4776-86BB-2A7A91B011C1Q48276843-3503D402-4AA8-4064-A8F4-45E948C2CA1BQ51767293-33B6D8F2-4578-405A-AA85-F0FDA8A0DD46Q53418756-3EA09C58-8EDE-457A-A579-4BAA548CBBC4
P2860
Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@ast
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@en
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@nl
type
label
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@ast
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@en
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@nl
prefLabel
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@ast
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@en
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@nl
P2093
P2860
P1433
P1476
Longitudinal modeling of front ...... heterozygotes, and noncarriers
@en
P2093
B K Woodruff
C R Hoffman-Snyder
E M Reiman
R J Caselli
S Z Rapcsak
P2860
P304
P356
10.1212/WNL.0B013E3182167147
P407
P577
2011-04-01T00:00:00Z